Results 131 to 140 of about 118,635,816 (237)
The inhibitor kinetics type cannot be used by itself to determine auto‐ versus allo‐anti‐FVIII antibody type. To characterise inhibitor kinetics in inherited haemophilia A (HA) and acquired haemophilia A (AHA) patients in our centre, results show that inhibitors for both HA alloantibodies and AHA autoantibodies may exhibit either type I or type II ...
Cuicui Qiao +10 more
wiley +1 more source
Prepared by the World Federation of Hemophilia in collaboration with the World Health Organization79 ...
World Health Organization +3 more
core
A case of acquired hemophilia A
We describe the case of a 82 years old female, who has been referred to the emergency department for a grosstrauma of the right knee after an accidental fall.
Ippolito, L., LIPPI, Giuseppe
core +1 more source
Acquired Hemophilia Developing After Whipple Operation
Acquired hemophilia A (AHA) is a rare bleeding disorder. It is caused by autoantibodies produced against endogenous coagulation factors, without a family history of hemophilia. The incidence has been reported as 1.4 per million.
Nebi Acar, İsmail Hasırcı
doaj +1 more source
Future directions in acquired hemophilia A [PDF]
Siragusa, Sergio, Napolitano, Mariasanta
openaire +3 more sources
The Human Biomarker Navigator integrates the disease continuum, biomarker dynamics, cross‐organ biomarker networks, biomarker classification, and technology‐driven paradigms. It maps how biomarkers link multi‐system physiology and pathology across the nervous, respiratory, endocrine, circulatory, immune, digestive, urinary, reproductive, and ...
Meng‐Yao Li +29 more
wiley +1 more source
This in vitro workflow illustrates the time‐and temperature‐dependent behavior of acquired FV inhibitors. Patient plasma was centrifuged and serially diluted, followed by parallel incubation at room temperature and 37°C. Serial measurements of APTT mixing test and residual FV activity were recorded across incubation time points to monitor inhibitor ...
Lihua Zhang +6 more
wiley +1 more source
ABSTRACT As cell and gene therapies (CGTs) advance through clinical trials into clinical practice, it becomes increasingly important for genetic counselors (GCs) to understand these therapeutics to discuss them with patients. Despite the apparent need for GCs to obtain CGT‐related education, little is known about the training GCs receive on CGT topics ...
Mariel Sebby +4 more
wiley +1 more source

